Pharmacokinetic study of high-dose oral rifampicin in critically Ill patients with multidrug-resistant Acinetobacter baumannii infection

被引：0
|
作者：
Hossein Karballaei-Mirzahosseini
Romina Kaveh-Ahangaran
Bita Shahrami
Mohammad Reza Rouini
Atabak Najafi
Arezoo Ahmadi
Sima Sadrai
Amirmahdi Mojtahedzadeh
Farhad Najmeddin
Mojtaba Mojtahedzadeh
机构：
[1] Tehran University of Medical Sciences,Department of Clinical Pharmacy, School of Pharmacy
[2] Tehran University of Medical Sciences,Department of Pharmaceutics, School of Pharmacy
[3] Tehran University of Medical Sciences,Department of Anesthesiology and Critical Care, School of Medicine
[4] Semmelweis University,Faculty of Medicine
[5] Tehran University of Medical Sciences,Research Center for Rational Use of Drugs
来源：
DARU Journal of Pharmaceutical Sciences | 2022年 / 30卷
关键词：
Rifampin; Gram-negative Bacilli Infection; Critical Illness; Sepsis; Antimicrobial Resistance; Carbapenem-resistant Acinetobacter Baumanni;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：311 / 322
页数：11
相关论文
共 50 条
  • [41] Efficacy and Safety of a Colistin Loading Dose, High-Dose Maintenance Regimen in Critically Ill Patients With Multidrug-Resistant Gram-Negative Pneumonia
    Elefritz, Jessica L.
    Bauer, Karri A.
    Jones, Christian
    Mangino, Julie E.
    Porter, Kyle
    Murphy, Claire V.
    JOURNAL OF INTENSIVE CARE MEDICINE, 2017, 32 (08) : 487 - 493
  • [42] In-vitro activity of the combination of colistin and rifampicin against multidrug-resistant strains of Acinetobacter baumannii
    Hogg, GM
    Barr, JG
    Webb, CH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (04) : 494 - 495
  • [43] Efficacy of High-dose Nebulized Colistin in Ventilator-associated Pneumonia Caused by Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
    Lu, Qin
    Luo, Rubin
    Bodin, Liliane
    Yang, Jianxin
    Zahr, Noel
    Aubry, Alexandra
    Golmard, Jean-Louis
    Rouby, Jean-Jacques
    ANESTHESIOLOGY, 2012, 117 (06) : 1335 - 1347
  • [44] High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii
    Betrosian, Alex P.
    Frantzeskaki, Frantzeska
    Xanthaki, Anna
    Georgiadis, George
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 39 (01) : 38 - 43
  • [45] Synergistic efficacy of meropenem and rifampicin in a murine model of sepsis caused by multidrug-resistant Acinetobacter baumannii
    Sun, Yuan
    Wang, Lei
    Li, Jiankang
    Zhao, Chongbo
    Zhao, Jinyi
    Liu, Meiyou
    Wang, Shan
    Lu, Chengtao
    Shang, Gangwei
    Jia, Yanyan
    Wen, Aidong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 729 : 116 - 122
  • [46] Carbapenem and multidrug-resistant Acinetobacter baumannii colonisation/infection: Epidemiology and factors associated with infection
    Hernandez-Torres, Alicia
    Garcia-Vazquez, Elisa
    Gomez, Joaquin
    Canteras, Manuel
    Ruiz, Joaquin
    Fernandez-Rufete, Ana
    Antonio Herreroa, Jose
    Yaguee, Genoveva
    MEDICINA CLINICA, 2010, 135 (09): : 389 - 396
  • [47] High tigecycline resistance in multidrug-resistant Acinetobacter baumannii -: authors' response
    Navon-Venezia, Shiri
    Leavitt, Azita
    Carmeli, Yehuda
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (01) : 178 - 179
  • [48] Treatment for patients with multidrug resistant Acinetobacter baumannii pulmonary infection
    Pan, Tao
    Liu, Xiaoyun
    Xiang, Shougui
    Ji, Wenli
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (04) : 1345 - 1347
  • [49] Burden of Multidrug-Resistant Acinetobacter baumannii Infection in Hospitalized Patients in a Tertiary Care Hospital of Nepal
    Yadav, Santosh Kumar
    Bhujel, Rajshree
    Hamal, Pradip
    Mishra, Shyam Kumar
    Sharma, Sangita
    Sherchand, Jeevan Bahadur
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 725 - 732
  • [50] RETROSPECTIVE ANALYSIS ON PATIENTS WITH INFECTION OF MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII: THE COMBINATION OF POLYMYXIN B AND TIGECYCLINE
    Du, Xiao
    Tong, Hanwen
    He, Bin
    Liu, Yang
    Shao, Binxia
    ACTA MEDICA MEDITERRANEA, 2022, 38 (03): : 1771 - 1776
12345